Risk factors of malignancy
I. V. Druk,
E. V. Semenova,
E. N. Loginova,
O. Yu. Korennova,
A. A. Semyonkin,
E. A. Lyalyukova,
E. V. Nadey https://doi.org/10.31146/1682-8658-ecg-205-9-116-128
Abstract
Prevention strategies aim to change environmental and lifestyle risk factors that contribute to the development of cancer. Screening detects abnormalities before they become clinically apparent, allowing intervention either before cancer develops or at an early stage when treatment is most likely to be effective. Despite reliable data on factors that reduce the risk of neoplasms, in routine clinical practice, the effectiveness of cancer prevention is still not high enough. This determines the high importance of the topic of this review, which summarizes the current scientific data on risk factors for the development of oncopathology and ways to influence them. Such risk factors as lifestyle, alcohol and tobacco use, physical activity, nutrition and other environmental factors are considered. A large role is given to infections, which is also considered in this review. The article highlights the intake of vitamins and microelements for the purpose of cancer prevention, as well as the influence of certain drugs taken to treat non-oncological diseases on the development of oncopathology. The purpose of the review is to present an analysis of current literature data on the methods of cancer prevention.
About the Authors
I. V. Druk
Omsk State Medical University
Russian Federation
Russian Federation
E. V. Semenova
Omsk State Medical University
Russian Federation
Russian Federation
E. N. Loginova
Omsk State Medical University
Russian Federation
Russian Federation
O. Yu. Korennova
Omsk State Medical University
Russian Federation
Russian Federation
A. A. Semyonkin
Omsk State Medical University
Russian Federation
Russian Federation
E. A. Lyalyukova
Omsk State Medical University
Russian Federation
Russian Federation
E. V. Nadey
Omsk State Medical University
Russian Federation
Russian Federation
References
1. Colditz G. A., Wolin K. Y., Gehlert S. Applying what we know to accelerate cancer prevention. Sci Transl Med. 2012;4(127):127rv4. https://doi.org/10.1126/scitranslmed.3003218
2. Emmons K. M., Colditz G. A. Realizing the Potential of Cancer Prevention - The Role of Implementation Science. N Engl J Med. 2017;376(10):986-990. https://doi.org/10.1056/NEJMsb1609101
3. Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
4. Colditz G. A., Atwood K. A., Emmons K., et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control. 2000;11(6):477-488. https://doi.org/10.1023/a:1008984432272
5. Danaei G., Vander Hoorn S., Lopez A. D., et al.Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784-1793. https://doi.org/10.1016/S0140-6736(05)67725-2
6. Romaguera D., Vergnaud A. C., Peeters P. H., et al. Is concordance with World Cancer Research Fund/American Institute for Cancer Research guidelines for cancer prevention related to subsequent risk of cancer? Results from the EPIC study. Am J Clin Nutr. 2012;96(1):150-163. https://doi.org/10.3945/ajcn.111.031674
7. Ford E. S., Bergmann M. M., Kröger J., et al. Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study. Arch Intern Med. 2009;169(15):1355-1362. https://doi.org/10.1001/archinternmed.2009.237
8. Li Y., Schoufour J., Wang D. D., et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. BMJ. 2020;368: l6669. https://doi.org/10.1136/bmj.l6669
9. de Martel C., Georges D., Bray F., et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):180-190. https://doi.org/10.1016/S2214-109X(19)30488-7
10. Brawley O. W. Avoidable cancer deaths globally. CA Cancer J Clin. 2011;61(2):67-68. https://doi.org/10.3322/caac.20108
11. Henley S. J., Thomas C. C., Sharapova S. R., et al. Vital Signs: Disparities in Tobacco-Related Cancer Incidence and Mortality - United States, 2004-2013. MMWR Morb Mortal Wkly Rep. 2016;65(44):1212-1218. https://doi.org/10.15585/mmwr.mm6544a3
12. Centers for Disease Control and Prevention (CDC). State-specific smoking-attributable mortality and years of potential life lost - United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2009;58(2):29-33.
13. Thun M. J., Heath C. W. Jr. Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Prev Med. 1997;26(4):422-426. https://doi.org/10.1006/pmed.1997.0182
14. Sasco A. J., Secretan M. B., Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004; 45 Suppl 2: S3. https://doi.org/10.1016/j.lungcan.2004.07.998
15. Brownson R. C., Novotny T. E., Perry M. C. Cigarette smoking and adult leukemia. A meta-analysis. Arch Intern Med. 1993; 153:469-475.
16. Murphy A. B., Akereyeni F., Nyame Y. A., et al. Smoking and prostate cancer in a multi-ethnic cohort. Prostate. 2013; 73:1518-1528. https://doi.org/10.1002/pros.22699
17. Kenfield S. A., Stampfer M. J., Chan J. M., Giovannucci E. Smoking and prostate cancer survival and recurrence. JAMA. 2011; 305:2548-2555. https://doi.org/10.1001/jama.2011.879
18. Islami F., Moreira D. M., Boffetta P., Freedland S. J. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol. 2014; 66:1054-1064. https://doi.org/10.1001/jama.2011.879
19. Macacu A., Autier P., Boniol M., Boyle P. Active and passive smoking and risk of breast cancer: a meta-analysis. Breast Cancer Res Treat. 2015; 154:213-224. https://doi.org/10.1007/s10549-015-3628-4
20. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014.
21. Machii R., Saika K. Mortality attributable to tobacco by region based on the WHO Global Report. Jpn J Clin Oncol. 2012 May;42(5):464-465. https://doi.org/10.1093/jjco/hys063
22. Samet J. M. The 1990 Report of the Surgeon General: The Health Benefits of Smoking Cessation. Am Rev Respir Dis. 1990; 142:993-994. https://doi.org/10.1164/ajrccm/142.5.993
23. Vineis P., Alavanja M., Buffler P., et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst. 2004; 96:99-106. https://doi.org/10.1093/jnci/djh014
24. Haughton B., Stang J. Population risk factors and trends in health care and public policy. J Acad Nutr Diet. 2012;112(3 Suppl): S35-46. https://doi.org/10.1016/j.jand.2011.12.011
25. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA. 2000; 283:3244-3254. https://doi.org/10.1001/jama.283.24.3244
26. Seitz H. K., Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007; 7:599-612. https://doi.org/10.1038/nrc2191
27. Theruvathu J. A., Jaruga P., Nath R. G., et al. Polyamines stimulate the formation of mutagenic 1, N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res. 2005; 33:3513-3520. https://doi.org/10.1093/nar/gki661
28. Boffetta P., Hashibe M. Alcohol and cancer. Lancet Oncol. 2006; 7:149-156. https://doi.org/10.1016/S1470-2045(06)70577-0
29. Matthews C. E., Moore S. C., Arem H., et al. Amount and Intensity of Leisure-Time Physical Activity and Lower Cancer Risk. J Clin Oncol. 2020; 38:686-697. https://doi.org/10.1200/JCO.19.02407
30. Moore S. C., Lee I. M., Weiderpass E., et al. Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. JAMA Intern Med. 2016; 176:816-825. https://doi.org/10.1001/jamainternmed.2016.1548
31. Inoue M., Yamamoto S., Kurahashi N., et al. Daily total physical activity level and total cancer risk in men and women: results from a large-scale population-based cohort study in Japan. Am J Epidemiol. 2008; 168:391-403. https://doi.org/10.1093/aje/kwn146
32. Harvard Report on Cancer Prevention. Volume 1: Causes of human cancer. Cancer Causes Control. 1996; 7 Suppl 1: S3. https://doi.org/10.1007/BF02352719
33. Maruti S. S., Willett W. C., Feskanich D., et al. A prospective study of age-specific physical activity and premenopausal breast cancer. J Natl Cancer Inst. 2008; 100:728-737. https://doi.org/10.1093/jnci/djn135
34. Bernstein L. Exercise and breast cancer prevention. Curr Oncol Rep. 2009; 11:490-496. https://doi.org/10.1007/s11912-009-0066-7
35. Wolin K. Y., Yan Y., Colditz G. A., Lee I. M. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer. 2009; 100:611-616. https://doi.org/10.1038/sj.bjc.6604917
36. Antonelli J. A., Jones L. W., Bañez L. L., et al. Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy. J Urol. 2009; 182:2226-2231. https://doi.org/10.1016/j.juro.2009.07.028
37. Patel A. V., Rodriguez C., Jacobs E. J., et al. Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men. Cancer Epidemiol Biomarkers Prev. 2005; 14:275-279.
38. Colditz G. A., Cannuscio C. C., Frazier A. L. Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control. 1997; 8:649-667.
39. Dallal C. M., Sullivan-Halley J., Ross R. K., et al. Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med. 2007; 167:408-415. https://doi.org/10.1001/archinte.167.4.408
40. Chao A., Connell C. J., Jacobs E. J., et al. Amount, type, and timing of recreational physical activity in relation to colon and rectal cancer in older adults: the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2004; 13:2187-2195.
41. Martínez M. E., Giovannucci E., Spiegelman D., et al. Leisure-time physical activity, body size, and colon cancer in women. Nurses’ Health Study Research Group. J Natl Cancer Inst. 1997; 89:948-955. https://doi.org/10.1093/jnci/89.13.948
42. Kehm R. D., Genkinger J. M., MacInnis R.J. et al. Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk. Cancer Res. 2020;80(1):116-125. https://doi.org/10.1158/0008-5472.CAN-19-1847
43. Simon T. G., Kim M. N., Luo X., et al. Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts. J Hepatol. 2020;72(6):1062-1069. https://doi.org/10.1016/j.jhep.2019.12.022
44. Boyle T., Keegel T., Bull F., et al. Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst. 2012; 104:1548-1561. https://doi.org/10.1093/jnci/djs354
45. Wolin K. Y., Yan Y., Colditz G. A. Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer. 2011; 104:882-885. https://doi.org/10.1038/sj.bjc.6606045
46. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994; 3:687-695.
47. Giovannucci E., Ascherio A., Rimm E. B., et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med. 1995; 122:327-334. https://doi.org/10.7326/0003-4819-122-5-199503010-00002
48. Martínez M. E., Heddens D., Earnest D. L., et al. Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst. 1999; 91:950-953. https://doi.org/10.1093/jnci/91.11.950
49. Lauby-Secretan B., Scoccianti C., Loomis D., et al. Body Fatness and Cancer - Viewpoint of the IARC Working Group. N Engl J Med. 2016; 375:794. https://doi.org/10.1093/jnci/91.11.950
50. Genser L., Barrat C. Long term outcomes after bariatric and metabolic surgery. Presse Med. 2018;47(5):471-479. French. https://doi.org/10.1016/j.lpm.2018.01.003
51. Schauer D. P., Feigelson H. S., Koebnick C., et al. Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort. Ann Surg. 2019; 269:95-101. https://doi.org/10.1097/SLA.0000000000002525
52. Aune D., Giovannucci E., Boffetta P., et al. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies.Int J Epidemiol. 2017;46(3):1029-1056. https://doi.org/10.1093/ije/dyw319
53. Boffetta P., Couto E., Wichmann J., et al. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2010; 102:529-537. https://doi.org/10.1093/jnci/djq072
54. Rock C. L., Thomson C., Gansler T., et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. 2020; 70:245-271. https://doi.org/10.3322/caac.21591
55. Grosso G., Bella F., Godos J., et al. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nutr Rev. 2017; 75:405-419. https://doi.org/10.1093/nutrit/nux012
56. Benetou V., Trichopoulou A., Orfanos P., et al. Conformity to traditional Mediterranean diet and cancer incidence: the Greek EPIC cohort. Br J Cancer. 2008; 99:191-195. https://doi.org/10.1038/sj.bjc.6604418
57. Couto E., Boffetta P., Lagiou P., et al. Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer. 2011; 104:1493-1499. https://doi.org/10.1038/bjc.2011.106
58. Le L. T., Sabaté J. Beyond meatless, the health effects of vegan diets: findings from the Adventist cohorts. Nutrients. 2014; 6:2131-2147. https://doi.org/10.3390/nu6062131
59. Brennan S. F., Cantwell M. M., Cardwell C. R., et al. Dietary patterns and breast cancer risk: a systematic review and meta-analysis. Am J Clin Nutr. 2010; 91:1294-1302. https://doi.org/10.3945/ajcn.2009.28796
60. Fiolet T., Srour B., Sellem L., et al. Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort. BMJ. 2018; 360: k322. https://doi.org/10.1136/bmj.k322
61. Chan D. S., Lau R., Aune D., et al. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One. 2011; 6: e20456. https://doi.org/10.1371/journal.pone.0020456
62. Wu K., Spiegelman D., Hou T., et al. Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies.Int J Cancer. 2016; 138:2368-2382. https://doi.org/10.1002/ijc.29973
63. Wolk A. Potential health hazards of eating red meat. J Intern Med. 2017; 281:106-122. https://doi.org/10.1111/joim.12543
64. Bouvard V., Loomis D., Guyton K. Z., et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015; 16:1599-1600. https://doi.org/10.1016/S1470-2045(15)00444-1
65. Benetou V., Orfanos P., Lagiou P., et al. Vegetables and fruits in relation to cancer risk: evidence from the Greek EPIC cohort study. Cancer Epidemiol Biomarkers Prev. 2008; 17:387-392. https://doi.org/10.1016/S1470-2045(15)00444-1
66. Takachi R., Inoue M., Ishihara J., et al. Fruit and vegetable intake and risk of total cancer and cardiovascular disease: Japan Public Health Center-Based Prospective Study. Am J Epidemiol. 2008; 167:59-70. https://doi.org/10.1093/aje/kwm263
67. Hung H. C., Joshipura K. J., Jiang R., et al. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst. 2004; 96:1577-1584. https://doi.org/10.1093/jnci/djh296
68. George S. M., Park Y., Leitzmann M. F., et al. Fruit and vegetable intake and risk of cancer: a prospective cohort study. Am J Clin Nutr. 2009; 89:347-353. https://doi.org/10.3945/ajcn.2008.26722
69. Feskanich D., Ziegler R. G., Michaud D. S., et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst. 2000; 92:1812-1823. https://doi.org/10.1093/jnci/92.22.1812
70. Smith-Warner S.A., Spiegelman D., Yaun S. S., et al.Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA. 2001; 285:769-776. https://doi.org/10.1001/jama.285.6.769
71. Michels K. B., Edward Giovannucci, Joshipura K. J., et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst. 2000; 92:1740-1752. https://doi.org/10.1093/jnci/92.21.1740
72. Koushik A., Hunter D. J., Spiegelman D., et al. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst. 2007; 99:1471-1483. https://doi.org/10.1093/jnci/djm155
73. Lee J. E., Chan A. T. Fruit, vegetables, and folate: cultivating the evidence for cancer prevention. Gastroenterology. 2011; 141:16-20. https://doi.org/10.1053/j.gastro.2011.05.020
74. Aune D., Chan D. S., Lau R., et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011; 343: d6617. https://doi.org/10.1136/bmj.d6617
75. Kavanaugh C. J., Trumbo P. R., Ellwood K. C. The U. S. Food and Drug Administration’s evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst. 2007; 99:1074-1085. https://doi.org/10.1093/jnci/djm037
76. Zu K., Mucci L., Rosner B. A., et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 2014; 106: djt430. https://doi.org/10.1093/jnci/djt430
77. Jung S., Spiegelman D., Baglietto L., et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst. 2013; 105:219-236. https://doi.org/10.1093/jnci/djs635
78. Wu A. H., Yu M. C., Tseng C. C., Pike M. C. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008; 98:9-14. https://doi.org/10.1038/sj.bjc.6604145
79. Yang G., Shu X. O., Chow W. H., et al. Soy food intake and risk of lung cancer: evidence from the Shanghai Women’s Health Study and a meta-analysis. Am J Epidemiol. 2012; 176:846-855. https://doi.org/10.1093/aje/kws168
80. Fink B. N., Steck S. E., Wolff M. S., et al. Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol. 2007; 165:514-523. https://doi.org/10.1093/aje/kwk033
81. Shin M. H., Holmes M. D., Hankinson S. E., et al.Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst. 2002; 94:1301-1311. https://doi.org/10.1093/jnci/94.17.1301
82. Knekt P., Järvinen R., Seppänen R., et al.Intake of dairy products and the risk of breast cancer. Br J Cancer. 1996; 73:687-691. https://doi.org/10.1038/bjc.1996.119
83. Boyd N. F., Martin L. J., Noffel M., et al. A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer. 1993; 68:627-636. https://doi.org/10.1038/bjc.1993.398
84. Lin J., Manson J. E., Lee I. M., et al.Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med. 2007; 167:1050-1059. https://doi.org/10.1001/archinte.167.10.1050
85. Missmer S. A., Smith-Warner S.A., Spiegelman D., et al. Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies.Int J Epidemiol. 2002; 31:78-85. https://doi.org/10.1093/ije/31.1.78
86. Qin L. Q., Xu J. Y., Wang P. Y., et al. Milk/dairy products consumption, galactose metabolism and ovarian cancer: meta-analysis of epidemiological studies. Eur J Cancer Prev. 2005; 14:13-19. https://doi.org/10.1097/00008469-200502000-00003
87. Genkinger J. M., Hunter D. J., Spiegelman D., et al. Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev. 2006; 15:364-372. https://doi.org/10.1158/1055-9965.EPI-05-0484
88. Larsson S. C., Orsini N., Wolk A. Milk, milk products and lactose intake and ovarian cancer risk: a meta-analysis of epidemiological studies.Int J Cancer. 2006; 118:431-441. https://doi.org/10.1002/ijc.21305
89. Mommers M., Schouten L. J., Goldbohm R. A., van den Brandt P. A. Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer. 2006; 94:165-170. https://doi.org/10.1038/sj.bjc.6602890
90. World Cancer Research Fund. Colorectal cancer: How diet, nutrition and physical activity affect colorectal (bowel) cancer risk. Available at: https://www.wcrf.org/dietandcancer/colorectal-cancer Accessed: 31.03.2022.
91. Norat T., Vieira A. R., Abar L., et al. World Cancer Research Fund international systematic literature review: The associations between food, nutrition and physical activity and the risk of colorectal cancer. Available at: https://www.wcrf.org/sites/default/files/colorectal-cancer-slr.pdf Accessed: 31.03.2022.
92. MacLean C.H., Newberry S. J., Mojica W. A., et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006; 295:403-415. https://doi.org/10.1001/jama.295.4.403
93. Andreeva V. A., Touvier M., Kesse-Guyot E., et al. B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial. Arch Intern Med. 2012; 172:540-547. https://doi.org/10.1001/archinternmed.2011.1450
94. World Cancer Research Fund. Endometrial cancer: How diet, nutrition and physical activity affect endometrial (womb) cancer risk. Available at: https://www.wcrf.org/dietandcancer/endometrial-cancer Accessed: 31.03.2022.
95. Vieira A. R., Abar L., Chan D. S.M., et al. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project. Ann Oncol. 2017;28(8):1788-1802. https://doi.org/10.1093/annonc/mdx171
96. Vastag B. Nutrients for prevention: negative trials send researchers back to drawing board. J Natl Cancer Inst. 2009; 101:446-448, 451. https://doi.org/10.1093/jnci/djp073
97. Coulter I. D., Hardy M. L., Morton S. C., et al. Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer. J Gen Intern Med. 2006; 21:735-744. https://doi.org/10.1111/j.1525-1497.2006.00483.x
98. Lin J., Cook N. R., Albert C., et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst. 2009; 101:14-23. https://doi.org/10.1093/jnci/djn438
99. Neuhouser M. L., Wassertheil-Smoller S., Thomson C., et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women’s Health Initiative cohorts. Arch Intern Med. 2009; 169:294-304. https://doi.org/10.1001/archinternmed.2008.540
100. Park S. Y., Murphy S. P., Wilkens L. R., et al. Multivitamin use and the risk of mortality and cancer incidence: the multiethnic cohort study. Am J Epidemiol. 2011; 173:906-914. https://doi.org/10.1093/aje/kwq447
101. Gaziano J. M., Sesso H. D., Christen W. G., et al. Multivitamins in the prevention of cancer in men: the Physicians’ Health Study II randomized controlled trial. JAMA. 2012; 308: 1871-80. https://doi.org/10.1001/jama.2012.14641
102. Qiao Y. L., Dawsey S. M., Kamangar F., et al. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst. 2009; 101: 507-18. https://doi.org/10.1093/jnci/djp037
103. Chung M., Lee J., Terasawa T., et al. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U. S. Preventive Services Task Force. Ann Intern Med. 2011; 155: 827-38. https://doi.org/10.7326/0003-4819-155-12-201112200-00005
104. Freedman D. M., Looker A. C., Abnet C. C., et al. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res. 2010; 70: 8587-97. https://doi.org/10.1158/0008-5472.CAN-10-1420
105. Pietinen P., Malila N., Virtanen M., et al. Diet and risk of colorectal cancer in a cohort of Finnish men. Cancer Causes Control. 1999; 10: 387-96. https://doi.org/10.1023/a:1008962219408
106. Garland C., Shekelle R. B., Barrett-Connor E., et al. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985; 1: 307-9. https://doi.org/10.1016/s0140-6736(85)91082-7
107. Wu K., Willett W. C., Fuchs C. S., et al. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst. 2002; 94: 437-46. https://doi.org/10.1093/jnci/94.6.437
108. Bonovas S., Fiorino G., Lytras T., et al. Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials. World J Gastroenterol. 2016; 22: 4594-603. https://doi.org/10.3748/wjg.v22.i18.4594
109. Veettil S. K., Ching S. M., Lim K. G., et al. Effects of calcium on the incidence of recurrent colorectal adenomas: A systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Medicine (Baltimore). 2017; 96: e7661. https://doi.org/10.1097/MD.0000000000007661
110. Wactawski-Wende J., Kotchen J. M., Anderson G. L., et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006; 354(10):1102.
111. Huncharek M., Muscat J., Kupelnick B. Dairy products, dietary calcium and vitamin D intake as risk factors for prostate cancer: a meta-analysis of 26,769 cases from 45 observational studies. Nutr Cancer. 2008;60(4):421-41. https://doi.org/10.1080/01635580801911779
112. Giovannucci E., Rimm E. B., Wolk A., et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res. 1998; 58:442-447.
113. Chan J. M., Stampfer M. J., Ma J., et al. Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. Am J Clin Nutr. 2001; 74: 549-54. https://doi.org/10.1093/ajcn/74.4.549
114. Rodriguez C., McCullough M.L., Mondul A. M., et al. Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men. Cancer Epidemiol Biomarkers Prev. 2003; 12:597-603.
115. Schuurman A. G., van den Brandt P. A., Dorant E., Goldbohm R. A. Animal products, calcium and protein and prostate cancer risk in The Netherlands Cohort Study. Br J Cancer. 1999; 80: 1107-13. https://doi.org/10.1038/sj.bjc.6690472
116. Chan J. M., Pietinen P., Virtanen M., et al. Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control. 2000; 11: 859-67. https://doi.org/10.1023/a:1008947201132
117. Lippman S. M., Klein E. A., Goodman P. J., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009; 301: 39-51. https://doi.org/10.1001/jama.2008.864
118. Klein E. A., Thompson I. M. Jr., Tangen C. M., et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011; 306: 1549-56. https://doi.org/10.1001/jama.2011.1437
119. Moyer V. A. U. S. Preventive Services Task Force. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U. S. Preventive services Task Force recommendation statement. Ann Intern Med. 2014; 160: 558-64. https://doi.org/10.7326/M14-0198
120. van Asperen I. A., Feskens E. J., Bowles C. H., Kromhout D. Body iron stores and mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men and women.Int J Epidemiol. 1995; 24: 665-70. https://doi.org/10.1093/ije/24.4.665
121. Knekt P., Reunanen A., Takkunen H., et al. Body iron stores and risk of cancer.Int J Cancer. 1994; 56: 379-82. https://doi.org/10.1002/ijc.2910560315
122. Zacharski L. R., Chow B. K., Howes P. S., et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008; 100: 996-1002. https://doi.org/10.1093/jnci/djn209
123. Duffield-Lillico A.J., Shureiqi I., Lippman S. M. Can selenium prevent colorectal cancer? A signpost from epidemiology. J Natl Cancer Inst. 2004;96(22):1645-7. https://doi.org/10.1093/jnci/djh332
124. Combs G. F. Jr. Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr. 2005; 135: 343-7. https://doi.org/10.1093/jn/135.2.343
125. Steevens J., van den Brandt P. A., Goldbohm R. A., Schouten L. J. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenterology. 2010; 138: 1704-13. https://doi.org/10.1053/j.gastro.2009.12.004
126. Sayehmiri K., Azami M., Mohammadi Y., et al. The association between Selenium and Prostate Cancer: a Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2018;19(6):1431-1437. https://doi.org/10.22034/APJCP.2018.19.6.1431
127. Vinceti M., Filippini T., Del Giovane C., et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018; 1: CD005195. https://doi.org/10.1002/14651858.CD005195.pub4
128. Eliassen A. H., Colditz G. A., Rosner B., et al. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006; 296: 193-201. https://doi.org/10.1001/jama.296.2.193
129. Luo J., Chlebowski R. T., Hendryx M., et al.Intentional Weight Loss and Endometrial Cancer Risk. J Clin Oncol. 2017; 35: 1189-1193. https://doi.org/10.1200/JCO.2016.70.5822
130. Chlebowski R. T., Luo J., Anderson G. L., et al. Weight loss and breast cancer incidence in postmenopausal women. Cancer. 2019; 125: 205-212. https://doi.org/10.1002/cncr.31687
131. Armstrong B. K., Cust A. E. Sun exposure and skin cancer, and the puzzle of cutaneous melanoma: A perspective on Fears et al. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. American Journal of Epidemiology. 1977; 105: 420-427. Cancer Epidemiol. 2017; 48: 147-156. https://doi.org/10.1016/j.canep.2017.04.004
132. Whiteman D. C., Whiteman C. A., Green A. C. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control. 2001; 12: 69-82. https://doi.org/10.1023/a:1008980919928
133. International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review.Int J Cancer. 2007; 120: 1116-22. https://doi.org/10.1002/ijc.22453
134. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636.
135. Hepatitis viruses. IARC Monogr Eval Carcinog Risks Hum. 1994;59:1-255.
136. Human T-cell lymphotropic viruses. IARC Monogr Eval Carcinog Risks Hum. 1996;67:261-390.
137. Deeken J. F., Tjen-A-Looi A., Rudek M. A., et al. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis. 2012 Nov;55(9):1228-35. https://doi.org/10.1093/cid/cis613
138. Parkin D. M. The global health burden of infection-associated cancers in the year 2002.Int J Cancer. 2006;118(12):3030-44. https://doi.org/10.1002/ijc.21731
139. Malnati M. S., Dagna L., Ponzoni M., Lusso P. Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. Rev Clin Exp Hematol. 2003; 7:375-405.
140. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994; 61:1-241.
141. Xia J., Jiang S. C., Peng H. J. Association between Liver Fluke Infection and Hepatobiliary Pathological Changes: A Systematic Review and Meta-Analysis. PLoS One. 2015; 10: e0132673. https://doi.org/10.1371/journal.pone.0132673
142. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Cervical Cytology screening. Number 45, August 2003.Int J Gynaecol Obstet. 2003; 83: 1409-1420. https://doi.org/10.1097/AOG.0b013e3181c6f8a4
143. US Preventive Services Task Force, Owens D. K., Davidson K. W., et al. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020; 323: 970-975. https://doi.org/10.1001/jama.2020.1123
144. Vangipuram R., Tyring S. K. AIDS-Associated Malignancies. Cancer Treat Res. 2019;177:1-21. https://doi.org/10.1007/978-3-030-03502-0_1
145. Sung J. J., Tsoi K. K., Wong V. W., et al. Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma. Aliment Pharmacol Ther. 2008; 28: 1067-77. https://doi.org/10.1111/j.1365-2036.2008.03816.x
146. Soriano V., Puoti M., Peters M., et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS. 2008;22(12):1399-410. https://doi.org/10.1097/QAD.0b013e3282f8b46f
147. Applegate T. L., Fajardo E., Sacks J. A. Hepatitis C Virus Diagnosis and the Holy Grail. Infect Dis Clin North Am. 2018;32(2):425-445. https://doi.org/10.1016/j.idc.2018.02.010
148. Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 1995; 6: 164-79. https://doi.org/10.1007/BF00052777
149. Giovannucci E., Harlan D. M., Archer M. C., et al. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010; 60: 1674-85. https://doi.org/10.2337/dc10-0666
150. Handelsman Y., Leroith D., Bloomgarden Z. T., et al. Diabetes and cancer - an AACE/ACE consensus statement. Endocr Pract. 2013 Jul-Aug;19(4):675-93. https://doi.org/10.4158/EP13248.CS
151. George S. M., Mayne S. T., Leitzmann M. F., et al. Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol. 2009; 169: 462-72. https://doi.org/10.1093/aje/kwn347
152. Augustin L. S., Dal Maso L., La Vecchia C., et al. Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Ann Oncol. 2001; 12: 1533-8. https://doi.org/10.1023/a:1013176129380
153. Jonas C. R., McCullough M.L., Teras L. R., et al. Dietary glycemic index, glycemic load, and risk of incident breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2003; 12:573-577.
154. Holmes M. D., Liu S., Hankinson S. E., et al. Dietary carbohydrates, fiber, and breast cancer risk. Am J Epidemiol. 2004; 159: 732-9. https://doi.org/10.1093/aje/kwh112
155. Nielsen T. G., Olsen A., Christensen J., et al. Dietary carbohydrate intake is not associated with the breast cancer incidence rate ratio in postmenopausal Danish women. J Nutr. 2005; 135: 124-8. https://doi.org/10.1093/jn/135.1.124
156. Higginbotham S., Zhang Z. F., Lee I. M., et al. Dietary glycemic load and breast cancer risk in the Women’s Health Study. Cancer Epidemiol Biomarkers Prev. 2004; 13: 65-70. https://doi.org/10.1158/1055-9965.epi-03-0066
157. Romieu I., Ferrari P., Rinaldi S., et al. Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr. 2012; 96: 345-355. https://doi.org/10.3945/ajcn.111.026724
158. Dong J. Y., Qin L. Q. Dietary glycemic index, glycemic load, and risk of breast cancer: meta-analysis of prospective cohort studies. Breast Cancer Res Treat. 2011; 126: 287-94. https://doi.org/10.1007/s10549-011-1343-3
159. Shikany J. M., Flood A. P., Kitahara C. M., et al. Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Cancer Causes Control. 2011; 22: 995-1002. https://doi.org/10.1007/s10552-011-9772-1
160. Higginbotham S., Zhang Z. F., Lee I. M., et al. Dietary glycemic load and risk of colorectal cancer in the Women’s Health Study. J Natl Cancer Inst. 2004; 96:229-233. https://doi.org/10.1093/jnci/djh020
161. Slattery M. L., Curtin K., Ma K., et al. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev. 2002; 11:541-548.
162. Terry P. D., Jain M., Miller A. B., et al. Glycemic load, carbohydrate intake, and risk of colorectal cancer in women: a prospective cohort study. J Natl Cancer Inst. 2003; 95:914-916. https://doi.org/10.1093/jnci/95.12.914
163. Michaud D. S., Fuchs C. S., Liu S., et al. Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2005; 14:138-147.
164. Aune D., Chan D. S., Lau R., et al. Carbohydrates, glycemic index, glycemic load, and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2012; 23: 521-35. https://doi.org/10.1007/s10552-012-9918-9
165. Li P., Wu H., Zhang H., et al. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Gut. 2015;64(9):1419-25. https://doi.org/10.1136/gutjnl-2014-308260
166. Figueiredo J. C., Jacobs E. J., Newton C. C., et al. Associations of Aspirin and Non-Aspirin Non-Steroidal Anti-Inflammatory Drugs With Colorectal Cancer Mortality After Diagnosis. J Natl Cancer Inst. 2021;113(7):833-840. https://doi.org/10.1093/jnci/djab008
167. Jacobs E. J., Thun M. J., Bain E. B., et al. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst. 2007; 99:608-15. https://doi.org/10.1093/jnci/djk132
168. Serrano D., Patrignani P., Stigliano V., et al. Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine. Genes (Basel). 2022;13(3):460. https://doi.org/10.3390/genes13030460
169. Chan A. T., Lippman S. M. Aspirin and colorectal cancer prevention in Lynch syndrome. Lancet. 2011; 378: 2051-2. https://doi.org/10.1016/S0140-6736(11)61216-6
170. Bosetti C., Santucci C., Gallus S., et al. Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019. Ann Oncol. 2020;31(5):558-568. https://doi.org/10.1016/j.annonc.2020.02.012
171. Gronich N., Rennert G. Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates. Nat Rev Clin Oncol. 2013; 10: 1620-5. https://doi.org/10.2337/dc08-2175
172. Libby G., Donnelly L. A., Donnan P. T., et al. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care. 2009; 32: 1620-5. https://doi.org/10.2337/dc08-2175
173. Landman G. W., Kleefstra N., van Hateren K. J., et al. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010; 322-6. https://doi.org/10.2337/dc09-1380
174. Decensi A., Puntoni M., Goodwin P., et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2010; 3:1451-61. https://doi.org/10.1158/1940-6207.CAPR-10-0157
175. Zhang Z. J., Zheng Z. J., Kan H., et al. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care. 2011; 34:2323-8. https://doi.org/10.2337/dc11-0512
176. Noto H., Goto A., Tsujimoto T., Noda M. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One. 2012; 7: e33411. https://doi.org/10.1371/journal.pone.0033411
177. Bodmer M., Becker C., Meier C., et al. Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis. Am J Gastroenterol. 2012; 107:620-626. https://doi.org/10.1038/ajg.2011.483
178. Alimova I. N., Liu B., Fan Z., et al. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle. 2009; 8:909-915. https://doi.org/10.4161/cc.8.6.7933
179. Vazquez-Martin A., Oliveras-Ferraros C., Menendez J. A. The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells. Cell Cycle. 2009; 8:88-89. https://doi.org/10.4161/cc.8.1.7499
180. Vázquez-Martín A., Oliveras-Ferraros C., del Barco S., et al. mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb). Clin Transl Oncol. 2009; 11:455-459. https://doi.org/10.1007/s12094-009-0384-0
181. Cholesterol Treatment Trialists’ (CTT) Collaboration, Emberson J. R., Kearney P. M., et al. Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One. 2012; 7: e29849. https://doi.org/10.1371/journal.pone.0029849
182. Haaland G. S., Falk R. S., Straume O., Lorens J. B. Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years. JAMA Intern Med. 2017; 177:1774-1780. https://doi.org/10.1001/jamainternmed.2017.5512
183. Tagalakis V., Blostein M., Robinson-Cohen C., Kahn S. R. The effect of anticoagulants on cancer risk and survival: systematic review. Cancer Treat Rev. 2007; 33:358-368. https://doi.org/10.1016/j.ctrv.2007.02.004
Review
For citations:
Druk I.V., Semenova E.V., Loginova E.N., Korennova O.Yu., Semyonkin A.A., Lyalyukova E.A., Nadey E.V. Risk factors of malignancy. Experimental and Clinical Gastroenterology. 2022;(9):116-128. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-205-9-116-128
Views:
346
ISSN 1682-8658 (Print)
Email this article 